Pedro Royo *

Autor invitado por SIIC

ESTUDIO DE LA VASCULARIZACION UTERINA MEDIANTE ANGIOGRAFIA 3D POWER DOPPLER EN LAS MUJERES CON DISMENORREA PRIMARIA

La angiografía 3D power-Doppler (3D PDA) es un método de evaluación útil y objetivo de la vascularización uterina, más concretamente la miometrial, que muestra su aumento, en las mujeres con dismenorrea primaria grave, éste podría corresponderse con estasis venosa intramiometrial.

*Pedro Royo
describe para SIIC los aspectos relevantes de su trabajo
THREE-DIMENSIONAL POWER DOPPLER ASSESSMENT OF UTERINE VASCULARIZATION IN WOMEN WITH PRIMARY DYSMENORRHEA
Institución principal de la investigación
*Hospital San Jorge de Huesca, Huesca, España
Imprimir nota

Referencias bibliográficas
1. Proctor M, Farquhar C. Diagnosis and management of dysmenorrhoea. BMJ 13:332(7550):1134-8, 2006.
2. Dmitrovic R, Peter B, Cvitkovic-Kuzmic A, Strelec M, Kereshi T. Severity of symptoms in primary dysmenorrhea--a Doppler study. Eur J Obstet Gynecol Reprod Biol 25:107(2):191-4, 2003.
3. Akerlund M. Vascularization of human endometrium. Uterine blood flow in healthy condition and in primary dysmenorrhoea. Ann N Y Acad Sci 30:734:47-56, 1994.
4. Altunyurt S, Göl M, Altunyurt S, Sezer O, Demir N. Primary dysmenorrhea and uterine blood flow: a color Doppler study. J Reprod Med 50(4):251-5, 2005.
5. Sladkevicius P, Valentin L, Marsál K. Blood flow velocity in the uterine and ovarian arteries during menstruation. Ultrasound Obstet Gynecol 1:4(5):421-7, 1994.
6. Raine-Fenning NJ, Campbell BK, Kendall NR, Clewes JS, Johnson IR. Quantifying the changes in endometrial vascularity throughout the normal menstrual cycle with three-dimensional power Doppler angiography. Hum Reprod 19(2):330-8, 2004.
7. Zaidi J, Jurkovic D, Campbell S, Pittrof R, McGregor A, Tan SL. Description of circadian rhythm in uterine artery blood flow during the peri-ovulatory period. Hum Reprod 10(7):1642-6, 1995.
8. Steinwall M, Bossmar T, Gaud C, Akerlund M. Inhibitory effects of SR 49059 on oxytocin-and vasopressin-induced uterine contractions in non-pregnant women. Acta Obstet Gynecol Scand 83(1):12-8, 2004.
9. Brouard R, Bossmar T, Fournié-Lloret D, Chassard D, Akerlund M. Effect of SR49059, an orally active V1a vasopressin receptor antagonist, in the prevention of dysmenorrhoea. BJOG 107(5):614-9, 2000.
10. Valentin l. Effects of a vasopressin antagonist in women with dysmenorrhea. Gynecologic and Obstetric Investigation 50(3):170-177, 2000.
11. Moya RA, Moisa CF, Morales F, Wynter H, Ali A, Narancio E. Transdermal glyceryl trinitrate in the management of primary dysmenorrhea. Int J Gynaecol Obstet 69(2):113-8, 2000.
12. Sun MF, Huang HC, Lin SC, Chang LP, Liu CF. Evaluation of nitric oxide and homocysteine levels in primary dysmenorrheal women in Taiwan. Life Sci 11:76(17):2005-9, 2005.
13. Pittrof R, Lees C, Thompson C, Pickles A, Martin JF, Campbell S. Crossover study of glyceryl trinitrate patches for controlling pain in women with severe dysmenorrhoea. BMJ 6:312(7035):884, 1996.
14. Dawood MY, Khan-Dawood FS. Differential suppression of menstrual fluid prostaglandin F2a, prostaglandin E2, 6-keto prostaglandin F1a and thromboxane B2 by suprofen in women with primary dysmenorrhea. Prostaglandins Other Lipid Mediat 83(1-2):146-53, 2007.
15. Cicinelli E, Einer-Jensen N, Galantino P, Alfonso R, Nicoletti R. The vascular cast of the human uterus: from anatomy to physiology. Ann NY Acad Sci 1034:19-26, 2004.
16. Bulletti C, DE Ziegler D, Setti PL, Cicinelli E, Polli V, Flamigni C. The patterns of uterine contractility in normal menstruating women: from physiology to pathology. Ann NY Acad Sci 1034:64-83, 2004.
17. Scultetus AH, Villavicencio JL, Gillespie DL. The nutcracker syndrome: its role in the pelvic venous disorders. J Vasc Surg 34(5):812-9, 2001.
18. Ahmed K, Sampath R, Khan MS. Current Trends in the Diagnosis and Management of Renal Nutcracker Syndrome: A Review. Eur J Vasc Endovasc Surg 31(4):410-6, 2006.
19. Liedman R, Grant L, Igidbashian S, James I, McLeod A, Skillernn L, Akerlund M. Intrauterine pressure, ischemia markers, and experienced pain during administration of a vasopressin V1a receptor antagonist in spontaneous and vasopressin-induced dysmenorrhea. Acta Obstetricia et Gynecologica 85:207-211, 2006.
20. Koyama T, Togashi K. Evaluation of uterine function by cine MR imaging. Int J CARS 1:459-460, 2006.
21. Kataoka M, Togashi K, Kido A, Nakai A, Fujiwara T, Koyama T, Fujii S. Dysmenorrhea: evaluation with cine-mode-dysplay MR imaging-Initial experience. Radiology 235(1):124-131, 2005.
22. Hoad CL, Fulford J, Raine-Fenning NJ, Campbell BK, Johnson IR, Gowland PA. In vivo perfusion, T1, and T2 measurements in the female pelvis during the normal menstrual cycle: a feasibility study. J Magn Reson Imaging 24(6):1350-6, 2006.